Field Effectiveness of Pandemic and 2009-2010 Seasonal Vaccines against 2009-2010 A(H1N1) Influenza: Estimations from Surveillance Data in France

被引:22
作者
Pelat, Camille [1 ,2 ]
Falchi, Alessandra [1 ,2 ]
Carrat, Fabrice [1 ,2 ,3 ]
Mosnier, Anne [4 ]
Bonmarin, Isabelle [5 ]
Turbelin, Clement [1 ,2 ]
Vaux, Sophie [5 ]
van der Werf, Sylvie [6 ,7 ,8 ]
Cohen, Jean Marie [4 ]
Lina, Bruno [9 ]
Blanchon, Thierry [1 ,2 ]
Hanslik, Thomas [2 ,10 ,11 ]
机构
[1] UPMC Univ Paris 06, UMRS 707, Paris, France
[2] INSERM, U707, Paris, France
[3] Hop St Antoine, Unite Sante Publ, Assistance Publ Hop Paris, F-75571 Paris, France
[4] Grp Regionaux Observat Grippe, Reseau GROG, Paris, France
[5] Inst Veille Sanit, St Maurice, France
[6] Inst Pasteur, Unit Mol Genet RNA Viruses, Natl Influenza Ctr No France, Dept Virol, Paris, France
[7] CNRS, URA3015, Paris, France
[8] Univ Paris Diderot, Paris, France
[9] Hosp Civils Lyon, Virol Lab, Ctr Biol & Pathol Est, CNR Virus Influenzae Reg Sud, Bron, France
[10] Hop Ambroise Pare, Serv Med Interne, Assistance Publ Hop Paris, Boulogne Billancourt, France
[11] Univ Versailles St Quentin en Yvelines, Versailles, France
来源
PLOS ONE | 2011年 / 6卷 / 05期
关键词
VACCINATION; ILLNESS; HOSPITALIZATIONS; EFFICACY; PEOPLE; SYSTEM;
D O I
10.1371/journal.pone.0019621
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: In this study, we assess how effective pandemic and trivalent 2009-2010 seasonal vaccines were in preventing influenza-like illness (ILI) during the 2009 A(H1N1) pandemic in France. We also compare vaccine effectiveness against ILI versus laboratory-confirmed pandemic A(H1N1) influenza, and assess the possible bias caused by using non-specific endpoints and observational data. Methodology and Principal Findings: We estimated vaccine effectiveness by using the following formula: VE = (PPV-PCV)/(PPV(1-PCV)) X 100%, where PPV is the proportion vaccinated in the population and PCV the proportion of vaccinated influenza cases. People were considered vaccinated three weeks after receiving a dose of vaccine. ILI and pandemic A(H1N1) laboratory-confirmed cases were obtained from two surveillance networks of general practitioners. During the epidemic, 99.7% of influenza isolates were pandemic A(H1N1). Pandemic and seasonal vaccine uptakes in the population were obtained from the National Health Insurance database and by telephonic surveys, respectively. Effectiveness estimates were adjusted by age and week. The presence of residual biases was explored by calculating vaccine effectiveness after the influenza period. The effectiveness of pandemic vaccines in preventing ILI was 52% (95% confidence interval: 30-69) during the pandemic and 33% (4-55) after. It was 86% (56-98) against confirmed influenza. The effectiveness of seasonal vaccines against ILI was 61% (56-66) during the pandemic and 19% (-10-41) after. It was 60% (41-74) against confirmed influenza. Conclusions: The effectiveness of pandemic vaccines in preventing confirmed pandemic A(H1N1) influenza on the field was high, consistently with published findings. It was significantly lower against ILI. This is unsurprising since not all ILI cases are caused by influenza. Trivalent 2009-2010 seasonal vaccines had a statistically significant effectiveness in preventing ILI and confirmed pandemic influenza, but were not better in preventing confirmed pandemic influenza than in preventing ILI. This lack of difference might be indicative of selection bias.
引用
收藏
页数:12
相关论文
共 43 条
[1]   Changes in the Viral Distribution Pattern after the Appearance of the Novel Influenza A H1N1 (pH1N1) Virus in Influenza-Like Illness Patients in Peru [J].
Alberto Laguna-Torres, Victor ;
Gomez, Jorge ;
Aguilar, Patricia V. ;
Ampuero, Julia S. ;
Munayco, Cesar ;
Ocana, Victor ;
Perez, Juan ;
Gamero, Maria E. ;
Carlos Arrasco, Juan ;
Paz, Irmia ;
Chavez, Edward ;
Cruz, Rollin ;
Chavez, Jaime ;
Mendocilla, Silvia ;
Gomez, Elizabeth ;
Antigoni, Juana ;
Gonzalez, Sofia ;
Tejada, Cesar ;
Chowell, Gerardo ;
Kochel, Tadeusz J. .
PLOS ONE, 2010, 5 (07) :1-8
[2]  
BAXTER R, 2010, VACCINE
[3]   Does this patient have influenza? [J].
Call, SA ;
Vollenweider, MA ;
Hornung, CA ;
Simel, DL ;
McKinney, WP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (08) :987-997
[4]  
CARCIONE D, 2010, EUROSURVEILL, V15
[5]   Flutracking provides a measure of field influenza vaccine effectiveness, Australia, 2007-2009 (vol 28, pg 6809, 2010) [J].
Carlson, Sandra J. ;
Durrheim, David N. ;
Dalton, Craig B. .
VACCINE, 2010, 28 (42) :6809-6810
[6]   Adaptive Vaccination Strategies to Mitigate Pandemic Influenza: Mexico as a Case Study [J].
Chowell, Gerardo ;
Viboud, Cecile ;
Wang, Xiaohong ;
Bertozzi, Stefano M. ;
Miller, Mark A. .
PLOS ONE, 2009, 4 (12)
[7]   Influenza virus: Immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines [J].
Cox, RJ ;
Brokstad, KA ;
Ogra, P .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2004, 59 (01) :1-15
[8]   Mortality reduction with influenza vaccine in patients with pneumonia outside "Flu" season - Pleiotropic benefits or residual confounding? [J].
Eurich, Dean T. ;
Marrie, Thomas J. ;
Johnstone, Jennie ;
Majumdar, Sumit R. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 178 (05) :527-533
[9]   Co-circulation of two genetically distinct sub-groups of A/H3N2 influenza strains during the 2006-2007 epidemic season in Corsica Island, France [J].
Falchi, Alessandra ;
Varesi, Laurent ;
Arena, Christophe ;
Leveque, Nicolas ;
Renois, Fanny ;
Blanchon, Thierry ;
Amoros, Jean Pierre ;
Andreoletti, Laurent .
JOURNAL OF CLINICAL VIROLOGY, 2009, 45 (03) :265-268
[10]   ESTIMATION OF VACCINE EFFECTIVENESS USING THE SCREENING METHOD [J].
FARRINGTON, CP .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1993, 22 (04) :742-746